Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium valproate in Rubinstein-Taybi syndrome: memory and functional imaging
2011-003784-30Phase 2
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valproic acid in Rubinstein-Taybi syndrome (RTS), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Long-term memory and learning performance.
02
Drugs
valproic acid
03
Conditions
Rubinstein-Taybi syndrome (RTS)
Beyond the preview
Go deeper on 2011-003784-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003784-30.